Germany Joins U.S. in Recall of Contaminated Heparin

Potentially lethal contaminated batches of the blood-thinning drug heparin have been discovered on the market in Germany. Producers have recalled heparin supplies from the German market following severe reactions to batches of the drug by up to 100 patients. The contamination cases in Germany follow the U.S. withdrawal last month of contaminated batches of heparin that have been linked to 19 patient deaths and up to 800 patients reporting adverse health effects. Villax: Enforcement is inadequate. U.S. officials have traced the contaminated heparin back to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers